2Blich M, Fruchter O, Edelstein S, et al. Somatostatin therapy ameliorates chronic and refractory gastrointestinal bleeding caused by diffuse angiodysplasia in a patient on anticoagulation therapy. Scand J Gastroenterol, 2003, 38: 801-803.
3Nardone G, Rocco A, Balzano T, et al. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther, 1999, 13: 1429-1436.
4Junquera F, Saperas E, Videla S, et al. Long-termefficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. Am J Gastroenterol, 2007, 102: 254-260.
5Orsi P, Guatti-Zuliani C, Okolicsanyi L. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract. Dig Liver Dis, 2001, 33: 330-334.
6Molina Infante J, Perez Gallardo B, Fernandez Bermejo M. Update on medical therapy for obscure gastrointestinal hemorrhage. Rev Esp Enferm Dig, 2007, 99: 457-462.
7Sakamoto M, Ueno T, Nakamura T, et al. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen. Eur J Ctin Invest, 2005, 35: 220-225.
8Panes J, Casadevall M, Fernandez M, et al. Gastric microcirculatory changes of portal-hypertensive rats can be attenuated by long term estrogen-progestagen treatment. Hepatology, 1994, 20: 1261-1270.
9Mosconi G, Mambelli E, Zanchelli F, et al. Severe gastrointestinal bleeding in a uremic patient treated with estrogen-progesterone therapy. Int J Artif Organs, 1999, 22: 313- 316.
10Granieri R, Mazzulla JP, Yarborough GW. Estrogen- progesterone therapy for recurrent gastrointestinal bleeding secondary to gastrointestinal angiodysplasia. Am J Gastroenterol, 1988,83 : 556-558.
1Garcia-Tsao G,Sanyal AJ,Grace N D.Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis[J].Hepatology,2007,1(3):922-938.
2Dagher L,Burroughs A.Variceal bleeding and portal hypertensive gastropathy[J].European Journal of Gastroenterology and Hepatology,2001,1(1):81.
